Pegasys Plus Entecavir Versus Entecavir Versus Pegasys for Hepatitis B e Antigen-Negative Chronic Hepatitis B

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01925820
Recruitment Status : Unknown
Verified December 2014 by National Taiwan University Hospital.
Recruitment status was:  Recruiting
First Posted : August 20, 2013
Last Update Posted : December 4, 2014
Roche Pharma AG
Information provided by (Responsible Party):
National Taiwan University Hospital

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2018
  Study Completion Date : No date given